Trial intelligence / Profile preview

Ezetimibe on Coronary Plaque Volume in ACS

NCT01068093Phase 4Unknown

Sponsor
Yokohama City University Medical Center
Start
Oct 2010
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ezetimibe in acute coronary syndrome (ACS), sponsored by Yokohama City University Medical Center. Status: unknown.

02

Drugs

ezetimibe
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT01068093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01068093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call